CD36 and fatty liver disease: In addition, it is also reported that CD36 is a shared downstream target of LXRα, PXR and PPARγ [74], and that LXRα-mediated CD36 induction is responsible for T0901317 treatment-mediated hepatic steatosis, which was abrogated in CD36 KO mice [74].